Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes
about
Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cellsHuman cord blood stem cell-modulated regulatory T lymphocytes reverse the autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) miceTargeting improves MSC treatment of inflammatory bowel diseaseCell therapies for pancreatic beta-cell replenishmentRole of stem cells during diabetic liver injuryRecent Trends in Therapeutic Approaches for Diabetes Management: A Comprehensive UpdateStem cell therapy to cure type 1 diabetes: from hype to hope.Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes MellitusConcise review: pancreas regeneration: recent advances and perspectivesCurrent stem cell based therapies in diabetesCell adhesion and long-term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapyMesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic NephropathyHuman mesenchymal stem cells suppress the stretch-induced inflammatory miR-155 and cytokines in bronchial epithelial cellsConcise Review: Fat and Furious: Harnessing the Full Potential of Adipose-Derived Stromal Vascular FractionThe role of bone marrow derived-mesenchymal stem cells in attenuation of kidney function in rats with diabetic nephropathy.A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.Recipient Glycemic Micro-environments Govern Therapeutic Effects of Mesenchymal Stem Cell Infusion on OsteopeniaMSC-derived Extracellular Vesicles Attenuate Immune Responses in Two Autoimmune Murine Models: Type 1 Diabetes and Uveoretinitis.Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus.The role of bone marrow mesenchymal stromal cell derivatives in skin wound healing in diabetic mice.The antidiabetic effect of MSCs is not impaired by insulin prophylaxis and is not improved by a second dose of cells.Mesenchymal stem cell therapy for nonhealing cutaneous woundsUnder a nonadherent state, bone marrow mesenchymal stem cells can be efficiently induced into functional islet-like cell clusters to normalize hyperglycemia in mice: a control studyMesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repairStem cell educator therapy and induction of immune balance.Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines.Human Bone Marrow Derived Mesenchymal Stem Cells Regulate Leukocyte-Endothelial Interactions and Activation of Transcription Factor NF-Kappa B.Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes.Differentiation of human adipose-derived mesenchymal stem cell into insulin-producing cells: an in vitro study.Reduction of acute rejection by bone marrow mesenchymal stem cells during rat small bowel transplantation.Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis?Cooperation by fibroblasts and bone marrow-mesenchymal stem cells to improve pancreatic rat-to-mouse islet xenotransplantationStem cell-derived islet cells for transplantationTransplantation of heterospheroids of islet cells and mesenchymal stem cells for effective angiogenesis and antiapoptosis.Adipose tissue-derived mesenchymal stem cells exert in vitro immunomodulatory and beta cell protective functions in streptozotocin-induced diabetic mice model.Macroporous three-dimensional PDMS scaffolds for extrahepatic islet transplantation.Stem cell approaches for diabetes: towards beta cell replacement.HCELL Expression on Murine MSC Licenses Pancreatotropism and Confers Durable Reversal of Autoimmune Diabetes in NOD Mice.Human embryonic stem cell-derived mesenchymal stromal cells.Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates.
P2860
Q21245299-1B1FA791-90D8-4735-B196-870B8C8E88D4Q21562482-5E0A40F4-6B1E-4E6A-B392-3062A48359FFQ24601626-1DD446A4-01AC-4DF2-B7A0-DD441062EE5DQ26741240-7E32AD6E-6CEB-4DA4-88A8-14F73E0CF160Q26773551-E9A785CC-F3F5-4152-9D7F-C2BD82CF619EQ26798145-34FF97BA-DD4A-40D3-A3E5-69F587D42C48Q26823294-E809C828-1B4E-4FE7-93EC-A845C20B43BCQ26864580-05ECDCF2-209B-4011-8BA2-2F6B37F94B13Q27013646-ACC58EF9-B0FF-4158-A742-267B605D0FFAQ28074914-AAEEDD74-0593-4B40-8D12-16F9149CA046Q28082334-6B360BCE-906F-4F98-91EE-97919E83AF12Q28354224-3AFABD0C-221A-49AC-AD2D-9CD6B68838E7Q28535304-2EBC3780-17D1-4364-806E-15DE818BAC68Q33553011-B014F96D-E86D-4645-9E51-A5E0FEDC746FQ33557060-A6BC6D3B-6757-41A6-B9EE-4256D1DB6509Q33570359-A9F85AED-C96C-4D4C-BB5C-12F19CBE8A75Q33588206-088B6A26-CF98-48B3-90C0-050DB9DE71F2Q33659353-99D48AA5-0F47-4306-B228-0F3DA4892219Q33719419-102BCA2B-6856-4595-A403-BE78483E5813Q33778239-F55B693E-7816-480A-A335-BEE36EE6859FQ33815233-9CBD3213-02E6-48D9-B66E-08D3C0A4DF24Q33825282-6C20BFAF-69A2-4CD4-B749-B1C29952C617Q33827066-8CCDCB49-9AF6-4C03-A372-2A090FE2A0C0Q33987579-1E038FE3-61A4-496E-B6B0-8965F874A988Q34290347-4BD9DE99-36DB-4C18-88F5-7E4550E2A220Q34292905-A2BF7C85-8C18-4E1C-80F0-26CEBD885418Q34306920-0717A314-F5F7-4140-9700-84EB873605C5Q34355278-B3E00C00-C9B8-4434-92BF-918FFD5E4188Q34524274-5516EA10-9D1F-4F6C-8E2B-671CE29E1CEEQ34702762-974D6890-4836-4414-AA28-76DB310C556CQ34779125-DEA53935-D768-4CA4-81E0-4A5059A274E2Q34979813-B1D39C39-F5FB-4C57-8F5C-51269C757DFDQ35156849-1904D485-FF74-42FB-BBE3-A19932DE3B47Q35167245-C51BB1B8-3993-40AB-86B7-DE10D4918C76Q35373250-D1B9E905-A0D9-44E8-97C3-ADEFE185320BQ35601055-CAEEEFC2-E6AB-40C2-8F94-E41C8FFE5699Q35617374-D4F00FDE-0A13-4BB1-B31E-9D19967AF996Q35660316-F54B03E7-B912-4A84-AD1A-77928A0F0D64Q35681446-2D9C890C-98CA-4C4A-BA89-1BAA2DF277DDQ35757109-A3D55291-C389-4906-B7FA-0E6F635D90C9
P2860
Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Immunomodulation by mesenchyma ...... c strategy for type 1 diabetes
@ast
Immunomodulation by mesenchyma ...... c strategy for type 1 diabetes
@en
Immunomodulation by mesenchyma ...... c strategy for type 1 diabetes
@nl
type
label
Immunomodulation by mesenchyma ...... c strategy for type 1 diabetes
@ast
Immunomodulation by mesenchyma ...... c strategy for type 1 diabetes
@en
Immunomodulation by mesenchyma ...... c strategy for type 1 diabetes
@nl
prefLabel
Immunomodulation by mesenchyma ...... c strategy for type 1 diabetes
@ast
Immunomodulation by mesenchyma ...... c strategy for type 1 diabetes
@en
Immunomodulation by mesenchyma ...... c strategy for type 1 diabetes
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Immunomodulation by mesenchyma ...... c strategy for type 1 diabetes
@en
P2093
Chaker N Adra
Mark Atkinson
Mohamed H Sayegh
P2860
P304
P3181
P356
10.2337/DB08-0180
P407
P5008
P577
2008-07-01T00:00:00Z